Cobra Biologics Holdings Limited, commonly referred to as Cobra Biologics, is a leading contract development and manufacturing organisation (CDMO) headquartered in the United Kingdom. Established in 2004, the company has made significant strides in the biopharmaceutical industry, specialising in the production of plasmid DNA, viral vectors, and cell and gene therapies. With operational facilities in both the UK and Sweden, Cobra Biologics serves a global clientele, providing innovative solutions that cater to the evolving needs of the life sciences sector. Cobra Biologics is renowned for its commitment to quality and regulatory compliance, offering bespoke services that streamline the development process for its partners. The company has achieved notable milestones, including successful collaborations with prominent biotech firms, solidifying its position as a trusted partner in the biomanufacturing landscape. With a focus on advancing therapeutic modalities, Cobra Biologics continues to play a pivotal role in the growth of the biopharmaceutical market.
We don't have data for Cobra Biologics Holdings Limited, but we can show you information about their parent organization instead.
View parent company